Web: Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

Article - Media

Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

May 05, 2020 0.6300 0.7300 0.5700 0.5800 0.5800 29,745,000
May 04, 2020 0.5200 0.5300 0.5000 0.5200 0.5200 1,597,600

Comment: NOW LOOK AT THE NEWS Just who would sell all that stock on that GREAT news (only a naked short seller TRAPPED).